| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |